Antibody Fragments and Their Purification by Protein L Affinity Chromatography
AbstractAntibodies and related proteins comprise one of the largest and fastest-growing classes of protein pharmaceuticals. A majority of such molecules are monoclonal antibodies; however, many new entities are antibody fragments. Due to their structural, physiological, and pharmacological properties, antibody fragments offer new biopharmaceutical opportunities. In the case of recombinant full-length antibodies with suitable Fc regions, two or three column purification processes centered around Protein A affinity chromatography have proven to be fast, efficient, robust, cost-effective, and scalable. Most antibody fragments lack Fc and suitable affinity for Protein A. Adapting proven antibody purification processes to antibody fragments demands different affinity chromatography. Such technology must offer the unit operation advantages noted above, and be suitable for most of the many different types of antibody fragments. Protein L affinity chromatography appears to fulfill these criteria—suggesting its consideration as a key unit operation in antibody fragment processing. View Full-Text
- Supplementary File 1:
Supplementary (AVI, 74119 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Rodrigo, G.; Gruvegård, M.; Van Alstine, J.M. Antibody Fragments and Their Purification by Protein L Affinity Chromatography. Antibodies 2015, 4, 259-277.
Rodrigo G, Gruvegård M, Van Alstine JM. Antibody Fragments and Their Purification by Protein L Affinity Chromatography. Antibodies. 2015; 4(3):259-277.Chicago/Turabian Style
Rodrigo, Gustav; Gruvegård, Mats; Van Alstine, James M. 2015. "Antibody Fragments and Their Purification by Protein L Affinity Chromatography." Antibodies 4, no. 3: 259-277.